We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-12.23%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$636M
AUM Growth
-$141M
Cap. Flow
-$21.7M
Cap. Flow %
-3.41%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$19.6M

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$14.3M
2
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$14M
3
SDS icon
ProShares UltraShort S&P500
SDS
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 96.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$354M 55.63%
15,966,038
-518,600
-3% -$14.3M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$187M 29.46%
2,589,235
+266,400
+11% +$19.6M
ALKS icon
3
Alkermes
ALKS
$8.82B
$59.7M 9.4%
1,030,639
– –
CLDX icon
4
Celldex Therapeutics
CLDX
$2.77B
$14.7M 2.31%
420,847
– –
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$10.5M 1.65%
400,000
– –
INDA icon
6
iShares MSCI India ETF
INDA
$6.71B
$9.9M 1.56%
290,000
– –
SDS icon
7
ProShares UltraShort S&P500
SDS
$406M
– –
-12,600
Closed -$12.9M
SPXU icon
8
ProShares UltraPro Short S&P 500
SPXU
$436M
– –
-3,075
Closed -$14M

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q1 2018 Portfolio in Review

As of Q1 2018, Meditor Group held 8 positions worth $636M, down 18% from $777M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $21.7M in Q1 2018, closing 2 positions and reducing 1 holding. Its most notable exit was ProShares UltraPro Short S&P 500, an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 94% a quarter earlier.

Against the trend, Meditor Group added an estimated $19.6M to Esperion Therapeutics.

  • Meditor Group added most to Esperion Therapeutics in Q1 2018, an estimated $19.6M increase.
  • Meditor Group's biggest Q1 2018 reduction was Exelixis, cutting an estimated $14.3M.
  • Meditor Group fully exited ProShares UltraPro Short S&P 500 in Q1 2018, selling an estimated $14M.
  • Meditor Group's ten largest holdings make up 100% of its $636M portfolio in Q1 2018.
  • Meditor Group opened 0 new positions and closed 2 in Q1 2018.
  • Meditor Group's portfolio value fell 18% quarter-over-quarter to $636M.

Based on Meditor Group's 13F filing for Q1 2018, filed 20 Apr 2018.